Fellow

Alan Boyd, CEO of Boyd Consultants Ltd, is a Pharmaceutical Physician who has made leading contributions to developing medicines in industry, facilitated numerous drug development programmes with academics, and driven the recognition for the new specialty of Pharmaceutical Medicine. His industry work developed multiple products that are now approved medicines for a wide range of indications. He is globally recognised as a pioneer in gene-based therapies, having led the development of the first gene therapy to be submitted for regulatory approval and being involved in five of the eight advanced therapies that are now approved medicines. As a Fellow of the Faculty of Pharmaceutical Medicine he established a postgraduate speciality programme which has supported GMC accreditation of 350 doctors enhancing the profile and impact of the speciality.